Introduction {#s1}
============

Intensive dairy farming may lead to negative health and welfare outcomes, including chronic painful lameness ([@B1]). Currently, chronic pain is recognized as a Central Nervous System (CNS) disease ([@B2]), and although no objective evidence has linked chronic pain with suffering in animals, we could not neglect the assumption that it may occur ([@B3]). Olsson et al. ([@B4]) indicate that animal suffering can be originated by exposure to different external or internal events that threaten biological functions. Chronic painful lameness significantly affects welfare ([@B5]) decreasing milk production and reproductive indexes, thus increasing early culling ([@B6]--[@B8]).

Cows with mild to severe lameness develop mechanical hyperalgesia of the dorsal aspect of the metatarsus ([@B9]), which is consistent with central sensitization, as secondary hyperalgesia is centrally and not peripherally mediated ([@B10]) and a positive association between hyperalgesia and the type of hoof injury has been reported ([@B11]). After injury, immune cells release pro-inflammatory cytokines at the site of injury, decreasing nociceptors threshold, leading to primary hyperalgesia ([@B12]--[@B14]). Several chronic painful conditions have reported elevated circulating levels of proinflammatory cytokines in humans ([@B15]). In lame cows diagnosed with interdigital dermatitis, Nazifi et al. ([@B16]) reported an increased in plasma TNF-α and IFN-γ. Additionally, pro-inflammatory cytokines can intensify the painful sensation acting directly in the CNS ([@B17]). Spinal cord cytokines can increase synaptic transmission toward supraspinal levels, enhancing pathological pain sensation and favoring central sensitization ([@B18]) which is a key element in chronic pain development and maintenance ([@B19]). Additionally, glial cells in the CNS react to signals associated with nociceptive transmission, morphologically changing into a reactive phenotype ([@B20]). Reactive microglia and astrocytes release cytokines, which in an autocrine and paracrine manner, facilitate neurons to glia and glia to glia communication, maintaining a state of neuroinflammation ([@B21], [@B22]). Moreover, the intrathecal administration of cytokines induces pain behavior in non-painful rodents ([@B23]); and the cerebrospinal concentration of cytokines correlates positively with pain intensity in humans with chronic pain ([@B24]). Although the role of proinflammatory cytokines in chronic pain is well-known, the spinal concentration of cytokines has not been reported in chronic lame cows. Here we hypothesize that chronic inflammatory lameness promotes persistent nociceptive input, which could induce changes in cytokine synthesis in the spinal cord. Therefore, the aim of this study was to determine the profile of cytokines in the spinal cord dorsal horn of dairy cows with painful chronic inflammatory lameness.

Materials and Methods {#s2}
=====================

The study and experimental protocol were reviewed and approved by the Ethics Committee for Animal Research of the Universidad Austral de Chile (N° 323/2018).

Animals and Lameness Assessment
-------------------------------

Animals were selected prospectively. Seven lame cows (Lame Group) were selected from a commercial dairy farm and seven non-lame cows (Non-Lame Group) were selected from a local slaughter-house. Selected animals included Holstein-Friesian ([@B4]) and Kiwi cross ([@B10]), weighing between 350 and 450 Kg with a parity range between 2 and 6. Inclusion criteria for lame cows included a history of chronic hind limb lameness caused by one of the most prevalent inflammatory hoof lesions previously described for Southern Chile, including white line disease, sole hemorrhage, heel erosion, sole ulcer and digital dermatitis ([@B25]). Animals were excluded if visible wounds, visible central or peripheral ataxia and acute or chronic mastitis were diagnosed. Lameness assessment was performed using a mobility scoring scale previously reported ([@B26]). Concisely, MS 0 not lame; MS 1 imperfect mobility/uneven; MS 2 impaired mobility/mildly lame; and MS 3 severely impaired/very lame. Only cows with the highest lameness score (MS = 3) were included in the lame group. Lame cows were euthanized at the dairy farm after general intravenous anesthesia and an intrathecal lidocaine injection at the atlanto-occipital foramen. Non-lame cows were euthanized at the slaughter-house by mechanically stunning and exsanguination following national regulations.

Spinal Cord Sampling and Protein Extraction
-------------------------------------------

Spinal cord samples were obtained immediately after euthanasia. Several lumbar spinal cord segments (L2--L4) were aseptically obtained after dissection of lumbar vertebrae. Bone tissue and meninges were removed, and spinal cord segments were thoroughly washed in cold phosphate-buffer saline (PBS), and then snap frozen in liquid nitrogen and stored at −80°C for further analysis. After unfreezing, dorsal horn segments were dissected, and 250 mg of tissue were homogenized in 1 mL of 4°C PBS using an Ultra Turrax tissue homogenizer at 4°C and 16,000 rpc three times for 30 s each. Homogenates were centrifuged at 20,000 x g for 10 min and supernatant was collected. Total protein concentration was quantified using the BSA Assay kit (Pierce^TM^ Thermo Scientific, Rochford USA).

Multiplex Cytokine Assay
------------------------

Cytokine analysis was performed using the Quantibody® Bovine Cytokine Array 1 kit (Ray Biotech) with an intra-assay coefficient of variation (CV) of \<20%. The kit allows for simultaneous analysis of tumor necrosis factor-alpha (TNF-α), interleukin-1alpha (IL-1α), interleukin 13 (IL-13), chemokine-10 (CXCL10/IP-10), chemokine-9 (CXCL9/MIG), interferon-alpha (IFN-α), interferon-gamma (IFN-γ), interleukin-21 (IL-21), interleukin-36ra (IL-36ra), and macrophage inflammatory protein-1 beta (MIP-1β). A total of 150 μg of protein were loaded into each well with standards loaded similarly. Signal intensity was visualized using a laser scanner using a 532 nm filter). Experiments were performed in duplicate. Each standard curve of cytokine concentration was fitted using Graphpad Prism software.

Statistical Analysis
--------------------

Data are presented as mean ± SEM. Normality of the data was checked using the Shapiro-Wilk test. Differences between lame and non-lame cows for each cytokine were evaluated using the *t*-test. Overall alpha was set to *p* \< 0.05. All analyses were performed using Graphpad Prism software (v7.0).

Results {#s3}
=======

Spinal cord dorsal horn samples obtained from lame cows had higher concentrations of TNF-α (*p* = 0.024), IL-1-α (*p* = 0.0339), IL-13 (*p* = 0.0204), CXCL10 (*p* = 0.025), CXCL9 (*p* = 0.0252), IFN-α (*p* = 0.0391), and IFN-γ (*p* = 0.0027) compared to non-lame cows. IL-21 was the only cytokine with lower concentration in the spinal cord of lame cows in comparison to control cows (*p* = 0.0044). Spinal concentration of IL-36ra was not significantly increased (*p* = 0.2505) in lame cows, while MIP-1β concentration remained unchanged between groups (*p* = 0.9078). All results are summarized in [Table 1](#T1){ref-type="table"}.

###### 

Spinal cord dorsal horn concentration of cytokines in Lame and Non-Lame cows.

                    **Lame**        **Non-lame**   ***P*-value**
  ----------------- --------------- -------------- ---------------
  TNF-α (pg/mL)     21.18 ± 5.41    5.02 ± 1.67    *P* = 0.0240
  IL-1α (pg/mL)     4.78 ± 1.35     1.38 ± 0.45    *P* = 0.0339
  IL-13 (pg/mL)     11.16 ± 1.35    5.06 ± 1.81    *P* = 0.0204
  CXCL10 (pg/mL)    34.00 ± 5.61    16.54 ± 3.99   *P* = 0.0250
  CXCL9 (pg/mL)     28.80 ± 6.69    9.04 ± 1.37    *P* = 0.0252
  IFN-α (pg/mL)     69.14 ± 19.23   16.07 ± 4.39   *P* = 0.0391
  IFN-γ (pg/mL)     3.10 ± 0.33     1.57 ± 0.09    *P* = 0.0027
  IL-21 (pg/mL)     27.80 ± 4.47    55.78 ± 6.38   *P* = 0.0044
  IL-36ra (pg/mL)   1.58 ± 0.53     0.90 ± 0.09    *P* = 0.2505
  MIP-1β (pg/mL)    1.20 ± 0.14     1.23 ± 0.18    *P* = 0.9078

Discussion {#s4}
==========

In this study we describe the profile of several cytokines in the dorsal horn of the spinal cord of dairy cows with chronic inflammatory lameness. Peripheral and Central Nervous (CNS) system cytokines contribute to central sensitization during chronic pain ([@B18], [@B27], [@B28]). Persistent pain leads to changes in the spinal cord including glial activation ([@B21], [@B29]). Neuropathic, inflammatory and neoplasic models of pain, and chronic opioid administration have shown to induce glial activation, increasing cytokine release, thus initiating and maintaining central sensitization ([@B22]). Additionally, resting microglia and astrocytes can be induced into a reactive state by pro-inflammatory cytokines. This cytokine-induced change in glia phenotype reveals that cytokines may have an autocrine/paracrine effect that facilitates neuron to glia or glia to glia communication during central sensitization ([@B30]). Moreover, cytokines are important modulators of neuronal functions ([@B18], [@B31]).

Spinal concentration of TNF-α was increased in lame cows. TNF-α is one of the most studied pro-inflammatory cytokines in the field of pain ([@B32]) and several experimental pain models have reported increased TNF-α expression in the CNS ([@B22]). It plays an important role in the development of central sensitization, mediating the expression and trafficking to the membrane of the AMPA receptor ([@B31], [@B33]), the phosphorylation of the NMDA receptor ([@B34]), and the increase in the frequency of spontaneous excitatory postsynaptic currents (EPSCs) ([@B18]). Zhang et al. ([@B35]) measured plasma TNF-α in transition cows before clinical signs of lameness, describing higher concentrations during the pre and postpartum, which suggested a state of clinical inflammation during that period. Similarly, Johnzon et al. ([@B36]) described an increased in TNF-α concentration both in plasma and milk after induction of mastitis in dairy cows. Although, the CSF concentration of TNF-α has not been reported in cows, our results are similar to those previously reported for human patients with chronic pain. Rozen and Swidan ([@B37]) described a marked increase in CSF and serum concentrations of TNF-α in human patients with persistent headache and chronic migraine. These results are in agreement with our finding in lame cows. Also, chronic inflammatory and neuropathic painful conditions have been associated with TNF-α secretion from reactive microglia ([@B38], [@B39]), which in turn promotes CXCL10 release from reactive astrocytes ([@B40]). TNF-α can also act as an autocrine factor in microglia, inducing the expression of several pro-inflammatory mediators ([@B30], [@B40], [@B41]).

IL-1α was increased in the spinal cord of lame cows. The role of IL-1α in inflammation has been extensively reported and recognized as an early trigger of the inflammatory response ([@B42]--[@B45]). Zhang et al. ([@B35]), described a state of subclinical inflammation during the prepartum of transition cows, which were characterized by lower concentrations of plasma IL-1α. Similar to our findings, higher concentrations of IL-1α have shown to occur in the spinal cord after dorsal root nerve compression ([@B28]) and in dorsal root ganglion (DRG) after peripheral nerve damage ([@B46]). Interestingly, both studies reported significant analgesia after the intrathecal administration of an IL-1α receptor antagonist. The potential role of IL-1α during chronic inflammation has been associated with the development of an inflammatory loop, triggered and maintained by IL-1α continuous secretion from damaged cells; which induces the autocrine and paracrine IL-1α expression from migrating cells with the subsequent expression of others cytokines and chemokines, including TNF-α, IL-8, IL-13, IL-6, CXCL9, and CXCL10 ([@B42], [@B47], [@B48]). We believe that the increased levels of cytokines detected in the spinal cord of lame cows could be the consequence of an inflammatory loop triggered by the augmented expression of IL-1α.

The spinal concentration of the anti-inflammatory cytokine IL-13 was increased in lame cows. IL-13 has been reported to increase in plasma, synovial fluid and muscular micro dialysate of patients with rheumatoid arthritis and jaw muscle pain, respectively ([@B49], [@B50]). The intraperitoneal administration of IL-13 induces marked analgesia in an inflammatory model of osteoarthritis and peritonitis ([@B51]), which confirms its anti-inflammatory properties. Similarly, the perineural injection of IL-13 reduced the pain threshold in rats with neuropathic pain ([@B52]). After injury and inflammation, neurons ([@B53]) and microglia ([@B54]) upregulate IL-13 in response to high levels of TNF-α and IFN-γ. This increase in IL-13 favors the downregulation of TNF-α, IL-1-β, and IFN-γ by macrophages ([@B51], [@B55]). Moreover, a neuroprotective role of IL-13 has been described ([@B56]). IL-13 induces apoptosis of reactive pro-inflammatory (M1) microglia ([@B54], [@B57]) or changes their phenotype into a protective type (M2) in order to suppress inflammation and promote healing ([@B58]).

Chemokines CXCL10 and CXCL9 were increased in the spinal cord of lame cows. Both chemokines are synthesized by immune cells in response to IFN-γ and TNF-α ([@B59]). IFN-γ-induced CXCL10 and CXCL9 expression has been reported in many inflammatory conditions of the CNS, including neuropathic pain ([@B60]--[@B62]). Accordingly, the *in vitro* administration of IFN-γ promotes microglial synthesis and release of CXCL10 and CXCL9 and astrocyte expression of CXCL-10 ([@B63], [@B64]). Therefore, the increased concentrations of spinal CXCL10 and CXCL9 in lame cows could indicate a response to high levels of IFN-γ and TNF-α. Nerve damage increases the spinal concentration of CXCL10 leading to hyperalgesia, which was successfully reverted after pharmacologic antagonism of its cognate receptor (CXC3R) ([@B65]). Also, the intrathecal injection of CXCL10 increased EPSCs and hyperalgesic behavior in rats ([@B66]). Recently, it has been proposed that CXCL10 plays an important role in microglia/astrocyte communication. In a bimodal inflammatory model in rats, a positive correlation between allodynia and microglial CXCL10/CXCR3 expression was followed by an increased astrocyte expression of CXCL10/CXCR3 ([@B67]).

In the present study, INF-α, a type I interferon member, was significantly upregulated in the spinal cord of lame cows. Its main role in the CNS is to be an important neuroprotective mechanism against viral infections ([@B68]). It is well-known that painful lameness in dairy cows is a consequence of peripheral inflammation ([@B69]). During peripheral inflammation, a marked increase in INF-α and its receptor in astrocytes and primary terminals afferents occurs ([@B70]). Interestingly, a significant interaction between INF-α and μ-opioids receptors has been documented, promoting analgesic properties of INF-α, which could explain some of its analgesic properties ([@B71]). Similarly, INF-α administered into the lateral ventricles in rats significantly reduced pain threshold ([@B72]) and its intrathecal administration attenuated hyperalgesic behavior in rats after hind paw injection of complete Freund\'s adjuvant ([@B70]). This analgesic INF-α dose was higher than the spinal concentration in lame and non-lame cows here reported, higher than the CSF concentration of human patients with CNS infection ([@B73]) and higher than those measured after traumatic brain injury ([@B74]). Prolonged INF-α therapy negatively impacts serotonin and monoamine function, stimulating excitatory transmission in rats ([@B75], [@B76]) and humans ([@B77]). According to Delgado ([@B78]), serotonergic and monoaminergic dysregulation have been proposed as a mechanism of chronic pain maintenance, reason why serotonin reuptake inhibitor drugs are frequently prescribed for treatment of chronic pain. Nonetheless, the INF-α effects over serotonergic transmission have not been studied thoroughly in chronic pain states. Although the increased spinal IFN-α concentration in lame cows here presented could be associated to an endogenous mechanism to control nociceptive transmission, a serotonergic dysregulation contributing to increased pain transmission cannot be completely ruled out.

IFN-γ is a type II pro-inflammatory cytokine that was increased in the spinal cord of lame cows. This result is similar to that described by Cuellar et al. ([@B79]), in which increased levels of IFN-γ were found in vertebral disc lavage samples from patients with chronic low back pain. It is known that neurons and astrocytes synthetize IFN-γ after nerve damage ([@B80]). Similarly, intrathecal administration of IFN-γ induces chronic pain behavior in rats ([@B81]) and systemic IFN-γ therapy in cancer patients induced spontaneous pain ([@B82]). Rats lacking the IFN-γ receptor did not express hyperalgesic behavior after nerve injury ([@B81], [@B83]).

IL-21 was the only downregulated cytokine in the spinal cord of lame cows. CD4^+^ T cells and natural killer T (NKT) cells produce IL-21, and augmented concentrations of brain IL-21 following experimental ischemia occurs after lymphocyte infiltration ([@B84]). A potential proinflammatory role of IL-21 in auto-immune and neurodegenerative diseases has been discussed ([@B85]). Interestingly, brain samples obtained from human patients with multiple sclerosis showed higher expression of IL-21 and its receptor, supporting a potential role of IL-21 in neurodegenerative diseases ([@B86]). Similarly, neuroinflammation promotes IL-21 expression by astrocytes ([@B87]). Although the role of IL-21 during chronic pain has not been thoroughly studied, Xue et al. ([@B23]) demonstrated that lumbar disc herniation induced an increased expression of IL-21, which positively correlated with pain intensity. Moreover, serum and synovial fluid from patients with rheumatoid arthritis showed high levels of IL-21 ([@B88]). In contrast, downregulation of IL-21 conferred resistance and neuroprotection against experimental brain ischemia in rats ([@B84]). According to this, it is possible that IL-21 downregulation in lame cows could reflect a protective response against neuroinflammation. However, more studies need to be performed in order to confirm this assumption.

Limitations of this study include the small sample size and a potential individual variability considering the multifactorial origin of bovine lameness. These aspects should be taken into account before results extrapolation. In this study, we were able to demonstrate that peripheral inflammation led to an increased concentration of cytokines in the dorsal horn of the spinal cord of chronically lame dairy cows. We believe that, as in humans, this state of neuroinflammation could have been initiated by sustained peripheral nociceptive transmission ([@B89], [@B90]). According to our results the impact of lameness in dairy cows is far beyond a local inflammation of the hoof, but also comprises inflammation of the CNS; with notorious and complex inflammatory events, involving IFN-γ, TNF-α, CXCL9, and CXCL10. The possible alteration in the spinal cytokine profile could indicate an orchestrated and self-perpetuated process in which IL-1α signaling pathway may play an important role. Additionally, the increased expression of anti-inflammatory cytokine IL-13, as well as the downregulation of IL-21 could indicate a physiological response in order to counteract the negative effects that prolonged inflammation of the spinal cord might exert on neurons and glia.

Conclusion {#s5}
==========

We conclude that painful chronic inflammation of the hoof in dairy cows leads to a marked increase in cytokine concentration in the dorsal horn of the spinal cord, which could represent a state of neuroinflammation of the Central Nervous System.
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